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The resemblance of the mammalian fetus to a homograft has raised the question as to why it is not rejected by the mother in the manner of a homograft. That portion of the fetus' genetic makeup which is derived from the father should afford sufficient histoincompatibility to evoke an immunologic response in the mother. It was at one time suggested that the onset of labor might result from the development of maternal homograft immunity against her fetuses, with their subsequent rejection. There are, however, various objections to this concept. For example, strains of animals inbred to the point of histocompatibility would on this basis be incapable of delivering their young, but no differences in gestation time have occurred in highly inbred strains of mice. In adclifton, various studies both in animals (1-3) and man (4) have not only failed to demonstrate the appearance of maternal homograft sensitization against the fetuses but on the contrary have shown that a degree of tolerance to paternal strain tissues may develop in the mother as a result of one or more pregnancies.
Although homograft sensitization of the mother does not appear to occur naturally, the mother can be experimentally sensitized against her fetuses. A degree of incompatibility can be achieved by grafts made before pregnancy from a prospective father to the mother, and subsequent transplants of tissue from the fetuses or offspring to the mother show the anticipated accelerated rejection (5). Despite such maternal sensitization, apparently normal pregnancies are possible. More recently, we have carried out experiments (6) in which, by using transplanted eggs, sensitization of a mother against both maternal and paternal components of the fetus' genetic makeup can be achieved. Under these conditions also, apparently normal young are born after a normal gestation time. Studies of this type demonstrate that a normal pregnancy is possible in the face of maternal sensitization against her fetuses. They do not, however, reveal whether some of the fetuses had been destroyed, leaving as survivors only a selected population of perhaps less incompatible fetuses. We have therefore carried out a series of experiments in which a rabbit sensitized by skin grafts against both members of one breeding pair was later simultaneously im-781 on jem.rupress.org
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planted with two kinds of eggs. One kind was derived from the sensitizing pair and the other from a second breeding pair against which no sensitization had been induced. We then compared the number of young born in the same pregnancy of each kind of egg. The results show that survival rates for the 2 kinds of eggs were almost identical, indicating that maternal sensitization against the fetuses did not demonstrably harm them.
Methods
Fertilized rabbit eggs were transplanted from each of two breeding pairs of rabbits to a recipient female previously sensitized against one breeding pair but not the other. The recipient female received ear skin homografts at monthly intervals from both members of one breeding pair at least 3 times before egg transplantation, again at the time of transplantation, and again in midpregnancy. TecI~niques of grafting and egg transplantation have been previously described (6) .
Both members of one of the egg donor pairs were New Zealand whites and of the other, chinchillas. The breed used as skin graft donors in a given family was selected by random numbers. The breed of the recipient rabbit was similarly randomized. And because the in vitro holding time of the eggs might influence their survival, the order in which eggs were flushed from the 2 donors (sensitizing and non-sensitizing) was randomized in such a way that there were equal numbers of each handled in each way. Equal numbers of eggs up to 10 from each donor were obtained and mixed together in 2 lots in such a way that half from each donor was washed into each of the recipient's fallopian tubes. The number of young subsequently born of eggs derived from each breeding pair was then counted; the two types of offspring were distinguishable by hair and skin color.
Testing to show that grafts from an egg donor pair sensitized the recipient mother against the transplanted fetuses have been previously reported (6) . Similar tests were carried out in one family (family 3) in the present series. After the birth of young, grafts from the egg donor pair were once again applied to the recipient mother, and at the height of rejection, a graft from an offspring born of one of their transplanted eggs was made to the recipient mother. A similar graft from a simultaneously born young derived from an egg of the non-sensitizing pair was used as a control; grafts from both kinds of offspring to an unrelated, ungrafted female served as additional controls. White graft rejection was taken as indication of preexisting sensitization. White graft rejection is both more rapid and qualitatively different from either first or second set rejection.
RESULTS
Sixteen female rabbits received a double implant of rabbit eggs (Table I) . Of these, II successfully delivered living young. One more died of unknown cause on day 29 of pregnancy (normal term: 30 to 32 days) and at autopsy had and those flushed from the second donor for 15 to 50 minutes. To evaluate the effect of the longer in vitro holding period on survival, the experiments have been sorted into 2 groups (Table II) , depending upon whether the sensitizing or non-sensitizing doe was flushed first. In each series, survival rates were somewhat lower for the eggs held for a longer time in vitro. S, sensitizing donor; NS, non-sensitizing donor. The egg recipient mother had been homograft-sensitized against one breeding pair (S) but not against a second pair (NS). Equal numbers of fertilized eggs from each pair were implanted into the same female at the same operation. Survival rates were not significantly different for the 2 kinds of fetuses.
* Mother died on day 29; 2 apparently normal term fetuses found at autopsy.
The results of grafting in family 3 to demonstrate sensitization of the egg recipient mother against her offspring are shown in Table III . A graft to the mother from a baby rabbit derived from the sensitizing pair was rejected in the time and manner of a white graft; a similar graft from a baby derived from the non-sensitizing pair was rejected in the time and manner of a first set graft, as on September 7, 2017 jem.rupress.org
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were the grafts from the 2 babies to a control female. The pattern of rejection indicates that the egg recipient mother bore homograft sensitivity specifically against young derived from the sensitizing pair and not against young carried in the same pregnancy but derived from the non-sensitizing pair. S, sensitizing donor; NS, non-sensitizing donor. Survival times of skin homografts from offspring to the egg-recipient mother and to a control female. The graft from the baby born of an egg from the sensitizing donor was rejected by the egg-recipient mother in the time and manner of a white graft, indicating a preexisting sensitization. All other grafts were rejected in the time and manner of first set grafts. In our experience (6), survival time of first set grafts (in days) was 7.9, a = 1.9, range = 6 to 14. Homograft sensitivity in the mother was therefore directed specifically against the offspring derived from the sensitizing donor.
* White graft.
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DISCUSSION
The present studies show once again under more critical conditions that the fetus which is the object of maternal homograft sensitization is in some way protected. The means by which such protection is afforded has become partially clarified. In a previous discussion (6), evidence was reviewed suggesting that neither an antigenic immaturity of the fetus (as distinct from the placenta) nor a reduced immunologic responsiveness of the mother was a likely possibility. The protective mechanism appeared to lie in the physical separation of the mother and fetus afforded by an intact placenta and in the special properties of the trophoblast. Several observations on the effectiveness of the placental barrier and pertinent to the homotransplantation problem are now available. The transfer of white cells from mother to fetus has been studied by Desai and Creger (7). Using atabrine-labeled maternal cells, they demonstrated at term only the occasional transfer of granulocytes, lymphocytes, and platelets from mother to fetus. The rarity with which labeled cells were found in fetal blood indicated the effectiveness of the placental barrier at term. Of the cells transferred, only the lymphocyte is known to have the potential of further division and colonization of the fetus. It would be of interest to extend these studies back to earlier fetal life. The human fetus at term probably has sufficient immunologic maturity to destroy invading maternal leukocytes. But earlier, during the period of immunologic tolerance, (a period not precisely defined in the human fetus), colonization by invading maternal lymphocytes should be possible. This would presumably be followed by runting (8) and either fetal death with abortion or perhaps by disease now unrecognized and lost in the illdefined group classed as dysmature infants. Whether or not the mammalian fetus is wholly protected against this eventuality is not known.
The placenta has been exposed experimentally to certain agents (hyaluronidase, reference 9 and x-radiation, reference 10) thought to damage it and to impair its etTectiveness as a barrier. With an appropriate adjustment of dosage of the presumably noxious agents, the fetuses were not destroyed, but after birth, the young showed a degree of tolerance to maternal skin homografts as evidence of immunologic contact with the mother in utero. Damage to the young was also apparent, though whether attributable to immunologic contact or the primary noxious agent was not certain.
Also of interest is the effectiveness of the placenta in preventing transfer of those circulating factors appearing in response to homografting and possibly playing a role in homograft rejection. These have been variously recognized (11) as hemolysins, leukoagglutinins, and cytotoxic and tumor protective antibodies, and of these, cytotoxic antibodies appear to be implicated in homograft rejection. Kaliss and coworkers (12) have recently found in mice that the growth of a tumor used to immunize a female during pregnancy was enhanced in her offspring. Enhancement appears to reflect the presence of a circulating antibody, on jem.rupress.org Downloaded from in this case transmitted from mother to offspring. Boyse (13) has suggested that enhancement results when the antigenic stimulus of a graft is blunted by the presence in the host of passively transferred cytotoxic antibody. The latter may be present at levels incapable of destroying the challenging graft, but none the less impairing the host's ability to respond with cytotoxic antibody production. Kaliss' observations on tumor growth do not show what would occur if maternal antibody was directed against the fetus, although neither homologous nor isohemolytic disease has as yet been recognized in mice. Using a test for cytotoxic antibody, we are presently studying this problem in rabbits.
The means by which the placenta itself is protected against maternal immunity appears to require special properties of the trophoblast. It has been suggested that this tissue, which is in direct contact with the mother, lacks homotransplantation antigens. The suggestion affords an adequate explanation of placental histocompatibility but is as yet without experimental support. On the contrary, 2 studies suggest that the trophoblast does have at least a degree of antigenic potency. Hulka (14) demonstrated that a globulin appearing in postpartum maternal sera was bound by cytoplasmic elements of the syncytiotrophoblast. He thought that production of antibody during pregnancy was masked by its continuous absorption and removal by the placenta. Douglas (15) was able to produce a typical lupus preparation by using the serum and polymorphonuclear cells from a patient with disseminated lupus erythematosis against the trophoblastic cells of the patient's own fetus. He concluded that nuclear material of the syncytiotrophoblast was antigenic. While the interpretation of these two experiments is open to some question, they at least raise doubt as to the suggested lack of antigenicity of the trophoblast.
We have found a lower survival rate of eggs transplanted after being held in vitro for a longer time. In our first 3 experiments we had overlooked this possibility. At that time, the systematic selection of the sensitizing donor to flush first yielded results initially suggesting a harmful effect of homograft sensitization on fetal survival. We became aware of the defect in our experimental design on reading an article by Menge and coworkers (16) , who encountered sharply falling survival rates with increasing time of in vitro holding. Subsequently in our work, randomization was carried out in a manner to correct for the initial disparity in the order of flushing eggs from the donors, and the final survival rates for the two types of eggs were virtually identical.
SUMMARY
The effect of homograft sensitization of a mother against her fetuses has been studied. A female rabbit was repeatedly grafted from both members of a breeding pair. Their offspring should and do become objects of homograft sensitization induced in the female by grafts from the parents. After sensitization was on September 7, 2017 jem.rupress.org Downloaded from established, fertilized ova were transplanted from the breeding pair to the sensitized female. At the same operation, an equal number of eggs was also transplanted to the same recipient from another breeding pair against which no sensitization had been induced. In 16 such families, the survival rates for offspring born of each type of egg were found to be almost identical, indicating that homograft sensitization in the mother directed against her fetuses did not demonstrably harm them. This work was supported by a grant from the Association for Aid to Crippled Children, New York City, and by grant HD 00536 from the National Institutes of Health, Public Health Service.
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